Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
OtherSymposium Article

GLUCURONIDATION AND THE UDP-GLUCURONOSYLTRANSFERASES IN HEALTH AND DISEASE

Peter G. Wells, Peter I. Mackenzie, Jayanta Roy Chowdhury, Chantal Guillemette, Philip A. Gregory, Yuji Ishii, Antony J. Hansen, Fay K. Kessler, Perry M. Kim, Namita Roy Chowdhury and Joseph K. Ritter
Drug Metabolism and Disposition March 2004, 32 (3) 281-290; DOI: https://doi.org/10.1124/dmd.32.3.281
Peter G. Wells
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter I. Mackenzie
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jayanta Roy Chowdhury
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chantal Guillemette
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip A. Gregory
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuji Ishii
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antony J. Hansen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fay K. Kessler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Perry M. Kim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Namita Roy Chowdhury
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph K. Ritter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 32 no. 3 281-290
DOI 
https://doi.org/10.1124/dmd.32.3.281
PubMed 
14977861

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received October 10, 2003
  • Accepted December 11, 2003
  • Published online February 20, 2004.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Peter G. Wells1,
  2. Peter I. Mackenzie1,
  3. Jayanta Roy Chowdhury1,
  4. Chantal Guillemette1,
  5. Philip A. Gregory,
  6. Yuji Ishii,
  7. Antony J. Hansen,
  8. Fay K. Kessler,
  9. Perry M. Kim,
  10. Namita Roy Chowdhury and
  11. Joseph K. Ritter1
  1. Faculty of Pharmacy and Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada (P.G.W., P.M.K.); Department of Clinical Pharmacology, Flinders Medical Centre, Adelaide, South Australia, Australia (P.I.M., P.A.G., A.J.H.); Graduate School of Pharmaceutical Sciences, Kyushu University (Y.I.), Fukuoka-shi, Kyushu, Japan; Albert Einstein College of Medicine, Yeshiva University, Bronx, New York (J.R.C., N.R.C.); Faculty of Pharmacy, Laval University, Quebec City, Quebec, Canada (C.G.); and Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia (J.K.R., F.K.K.)
  1. Address correspondence to:
    Dr. Joseph K. Ritter, Dept. of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, 410 N. 12th St., P.O. Box 980613, Richmond, VA 23298-0613. E-mail: jritter{at}mail2.vcu.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to September 2023

AbstractFullPdf
Aug 201724215
Sep 201794114
Oct 2017105119
Nov 201788421
Dec 2017114822
Jan 2018106010
Feb 201872912
Mar 201865210
Apr 201847825
May 2018105319
Jun 201846311
Jul 201854912
Aug 201893916
Sep 201883711
Oct 2018117518
Nov 20187809
Dec 20181175913
Jan 201967911
Feb 201951179
Mar 201954117
Apr 20194575
May 20193314
Jun 20194964
Jul 20195111
Aug 20193621
Oct 20193232
Nov 20194143
Dec 201946102
Jan 20204584
Feb 20206133
Mar 20202160
May 20203373
Jun 20203941
Jul 20201822
Aug 20201933
Sep 202036100
Oct 20202820
Nov 20201554
Dec 202060142
Jan 202154265
Feb 202136312
Mar 202165176
Apr 20215160
May 202143102
Jun 202142242
Jul 20211971
Aug 202128163
Sep 202148141
Oct 202170113
Nov 20214021
Dec 202157172
Jan 20223862
Feb 20223520
Mar 20227031
Apr 202247122
May 202256165
Jun 20222954
Jul 202242113
Aug 202231114
Sep 202257851
Oct 2022411534
Nov 202239221
Dec 20223030
Jan 202378101
Feb 20233591
Mar 20233981
Apr 202341293
May 202342192
Jun 202333151
Jul 202329111
Aug 202327252
Sep 202325170

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 32 (3)
Drug Metabolism and Disposition
Vol. 32, Issue 3
1 Mar 2004
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
GLUCURONIDATION AND THE UDP-GLUCURONOSYLTRANSFERASES IN HEALTH AND DISEASE
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherSymposium Article

GLUCURONIDATION AND THE UDP-GLUCURONOSYLTRANSFERASES IN HEALTH AND DISEASE

Peter G. Wells, Peter I. Mackenzie, Jayanta Roy Chowdhury, Chantal Guillemette, Philip A. Gregory, Yuji Ishii, Antony J. Hansen, Fay K. Kessler, Perry M. Kim, Namita Roy Chowdhury and Joseph K. Ritter
Drug Metabolism and Disposition March 1, 2004, 32 (3) 281-290; DOI: https://doi.org/10.1124/dmd.32.3.281

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherSymposium Article

GLUCURONIDATION AND THE UDP-GLUCURONOSYLTRANSFERASES IN HEALTH AND DISEASE

Peter G. Wells, Peter I. Mackenzie, Jayanta Roy Chowdhury, Chantal Guillemette, Philip A. Gregory, Yuji Ishii, Antony J. Hansen, Fay K. Kessler, Perry M. Kim, Namita Roy Chowdhury and Joseph K. Ritter
Drug Metabolism and Disposition March 1, 2004, 32 (3) 281-290; DOI: https://doi.org/10.1124/dmd.32.3.281
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Structure and Tissue-Specific Regulation of UGT Genes (P.I.M., P.A.G., Y.I., A.J.H.)
    • Glucuronidation of Xenobiotics and Endobiotics (J.K.R., F.K.K.)
    • Toxicological Relevance of UGTs (P.G.W., P.M.K.)
    • Pharmacogenetics of UGT Enzymes: Implications for Cancer Susceptibility (C.G.)
    • Gene Therapy for UGT Deficiencies (J.R.C., N.R.C.)
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Targeting Drug-Metabolizing Enzymes for Effective Chemoprevention and Chemotherapy
  • TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS
Show more SYMPOSIUM ARTICLES

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics